Symbiosis Appoints Wendy Cook as New Qualified Person  

Symbiosis Pharmaceutical Services, a global CMO specializing in the sterile manufacture of injectable drug products, has appointed Wendy Cook as a Qualified Person (QP) to further strengthen its regulatory and quality leadership team.

Wendy brings more than 20 years of pharmaceutical quality assurance experience across GLP, GCP and GMP environments, with experience in sterile manufacturing and clinical trial supply chains. Since qualifying as a QP in 2018, she has held roles at both CDMOs and global CMOs, where she oversaw batch certification, regulatory submissions and quality oversight across multiple dosage forms including sterile injectables.

The appointment follows Symbiosis’ successful MHRA inspection of its new 20,000 sq.-ft. GMP facility, which recently added a state-of-the-art automated sterile fill/finish line to the company’s commercial capabilities. 

Nicola Paterson, Lead QP at Symbiosis, said: “Wendy’s appointment strengthens our QP team at a pivotal time for Symbiosis. Her knowledge of GMP, regulatory expectations and sterile manufacturing adds significant expertise to our quality leadership. Combined with our recent regulatory approvals,  Wendy’s arrival underlines our commitment to delivering world-class regulatory support and compliant, flexible access to sterile manufacturing capacity for our clients”